Evelyn Sievert

Evelyn Sievert is currently serving as Scientist II at Vividion Therapeutics, Inc. since March 2022, previously holding the position of Scientist I in the same field. Prior experience includes work as a Graduate Student Researcher at UC Davis from September 2015 to March 2022, where significant contributions were made in understanding the role of the transcription factor IRF4 in B cell response within germinal centers, along with training graduate students in murine techniques. Previous roles as a Research Specialist at the University of Maryland School of Medicine involved developing immunohistochemistry assays and studying complement expression in xenografts. Evelyn Sievert holds a PhD in Immunology from the University of California, Davis and dual Bachelor's degrees in Biology and Fine Arts from the University of Maryland.